Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S10 pseudogene 20 (RPS10P20) is a non-coding DNA sequence classified as a processed pseudogene, meaning it is a genomic sequence that arose from the ribosomal protein S10 gene (RPS10) but has lost the ability to code for a functional protein.[1][6] Pseudogenes such as RPS10P20 may be present throughout the human genome, typically resulting from gene duplication or retrotransposition events, but do not contribute directly to cellular protein synthesis nor do they possess known biological or disease-related roles.[1] While the functional RPS10 gene encodes a critical component of the ribosome involved in protein synthesis and has some documented clinical significance, including roles in Diamond–Blackfan anemia, its pseudogenes—including RPS10P20—do not share these protein functions or disease associations.[1][3][7] No drugs, mechanisms of action, or biomarker utility have been attributed to RPS10P20.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S10 pseudogene 20 (RPS10P20).